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ABSTRACT
On current consumption patterns, about 400 million adults worldwide will be killed 
by  smoking  between  2010  and  2050.  Most  of  these  deaths  will  occur  among 
smokers currently alive. At least half will die at ages 30-69 years, losing decades of 
productive life. Smoking-attributable mortality has fallen sharply in high-income 
countries but will rise globally unless today’s smokers, most of whom live in low- 
and middle-income countries, quit smoking before or during middle age. The single 
most important intervention to raise cessation rates is a large increase in taxes. 
Tripling excise taxes on tobacco would raise cessation rates and deter smoking 
initiation. Higher taxes, regulations on smoking and information for consumers 
could avoid at least 115 million smoking deaths in the next few decades, including 
at least 25 million cancer deaths and 50 million vascular deaths.
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INTRODUCTION
Tobacco use kills about five to six million people annually worldwide, 
accounting for about 20 percent of all adult male deaths and five percent of 
adult female deaths, over age 30.1-5 On current smoking patterns, annual 
tobacco deaths will rise to about ten million by 2030. One hundred million 
tobacco deaths occurred in the 20th century, of which nearly 70 percent took 
place in high-income countries and in the former socialist economies of 
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Europe.1,6 By contrast, tobacco is expected to kill about one billion people 
in  the  21st  century,  with  most  from  low-  and  middle-income  countries 
outside North America and Europe.1 Without widespread cessation, about 
400 million tobacco deaths will occur between 2010 and 2050, mostly 
among current smokers. In the second half of the century, an additional 500 
million tobacco deaths are expected to occur, mostly among future smokers 
(Figure 1).
Fig. 1. Projected numbers of deaths from tobacco during the 21st century. The 
millions  of  smoking  deaths  are  shown  on  the  y-axis  over  time.  See  text  for 
explanation of how the estimates were derived. Note the differences in the scale 
used for the time periods of 25, 50 and 100 years.
Here, we argue that widespread use of a few powerful interventions 
comprising  higher  tobacco  prices,  information,  and  regulations,  could 
prevent several tens of millions of premature deaths over the next few 
decades. We first present the epidemiology of smoking-related disease, 
focusing on the harm to smokers themselves, but do not focus on the effects 
of smoking on others, or in the case for maternal health, the impact of 
smoking or tobacco use on fetal development and growth.2,4 We explain the 
relevance of the long delay between smoking onset and premature mortality 
to our understanding of future tobacco-related disease risks, and describe 
the  benefits  of  cessation.  We  also  outline  the  economic  rationale  for 
intervention  in  the  tobacco  markets,  and  discuss  the  effectiveness  of 
interventions to rapidly raise cessation rates in low- and middle-income 
countries.ReducingSmokingDeathsWorldwide 571
EPIDEMIOLOGY
Current smoking patterns
This review focuses on smoking because it accounts for the large majority 
(about 85%) of all tobacco produced worldwide,7 and because inhaled 
tobacco causes a greater diversity and incidence of disease compared to 
chewing  tobacco.8-10  Active  smoking  is  also  far  more  hazardous  than 
exposure to second-hand smoke,8,9,11 although the latter does contribute 
significantly to illness.12
Fig.  2.  Smoking  prevalence  at  ages  15  years  or  older,  by  gender,  in  selected 
countries, 2008-2010.
Source: From the Global Adult Tobacco Surveys.14-27
More than 1.1 billion people currently smoke worldwide. Of whom 
over 80 percent reside in low- and middle-income countries. Based on the 
2010  United  Nations  population  estimates,13  over  600  million  current 
smokers14-27 reside just in 14 countries (Bangladesh, Brazil, China, Egypt, 
India,  Mexico,  Philippines,  Poland,  Russia, Thailand, Turkey,  Ukraine, 
Uruguay, and Viet Nam). Data from the 2008-2010 Global Adult Tobacco 
Survey for adults aged 15 years and older implemented in these countries 
indicates that the proportion of adult men who smoke ranges from over 60 
percent in Russia, to about 20 percent in Brazil (Figure 2). Among adult 
women, the proportion of smokers ranges from 24 percent in Poland to 0.5 572 PublicHealthReviews,Vol.33,No2
percent in Egypt. There are as yet standardized survey data only from 
school children through the Global Youth Tobacco Survey (GYTS), which 
reveal significant rates of smoking among school age-children to about age 
15,  plus  some  evidence  that  the  male  predominance  of  smoking  is 
changing.28
The peradultconsumptionnumber of cigarettes smoked has more than 
halved in the last two to three decades in the United States, United Kingdom, 
Canada,  France  and  other  high-income  countries.29  In  contrast,  male 
smoking has risen sharply in many low- and middle-income countries such 
as China and Indonesia (Figure 3). In India, smoking most commonly 
occurs in the form of bidis, which are smaller than cigarettes and typically 
contain  only  about  a  quarter  as  much  tobacco.  Bidis  account  for 
approximately 85 percent of total smoked tobacco consumption in India, 
although cigarettes have been displacing bidis among younger males over 
the last 12 years.30 Brazil, exceptionally, has recorded decreases in the 
prevalence of adult smoking.31
Fig. 3. Trends in cigarette consumption and male lung cancer rates, 1920-2005. The 
number  of  cigarettes  consumed  per  adult  (men  are  used  as  the  appropriate 
denominator for cigarette smoking as few women currently smoke in Asia) and the 
age-standardised lung cancer rates are shown on the y-axes over time by country.ReducingSmokingDeathsWorldwide 573
Table 1
Prevalenceandnumberofcurrentandex-smokers
amongadultsinselectedcountries
Country
Prevalence (%) Number (millions)
Current 
smokers Ex-smokers
Current 
smokers Ex-smokers
Bangladesh (2009)* 23.0 6.0 22 6
Brazil (2008)* 17.2 18.2 25 26
China (2010)* 28.1 5.4 301 57
Egypt (2009)* 19.4 4.4 10 2
India (2009)* 14.0 2.9 111 23
Mexico (2009)* 15.9 14.6 11 10
Philippines (2009)* 28.2 11.3 17 7
Poland (2009)* 30.3 21.6 10 7
Russia (2009)* 39.1 13.8 44 16
Thailand (2009)* 23.7 12.1 12 6
Turkey (2008)* 31.2 15.9 16 8
Ukraine (2010)* 28.9 15.1 12 6
Uruguay (2009)* 25.0 24.0 6 6
Vietnam (2010)* 23.8 9.8 15 6
Canada (2009)** 17.0 26.0 5 7
UK (2009)***,† 21.0 25.3 10 13
USA (2010)‡ 19.3 21.1 44 49
Australia (2010)§ 18.0 24.1 3 4
Sub-totals for 
18 countries - - 674 261
Sources:
* GATS (Global Adult Tobacco Survey) (2008-2010)-Country Reports (ages 15+) (compiled 
from various country reports).
** Canada-CTUMS (Canadian Tobacco Use Monitoring Survey) (2009-2010) (http://www.
hc-sc.gc.ca/hc-ps/tobac-tabac/research-recherche/stat/ctums-esutc_2010_graph-eng.php) 
(ages 15+).
*** UK - General Life Style Survey (GLS), 2009 (ages 16+) (http://www.ons.gov.uk/ons/
publications/index.html?pageSize=50&newquery=smoking)  (in  UK,  ex-smokers  estimate 
represent ex-regular smokers and never smokers represent never-regularly smoked).
† Number of smokers are estimated using the 2010 revision of UN population obtained from 
http://esa.un.org/unpd/wpp/unpp/panel_indicators.htm (accessed on 5 Sept 2012).
‡ USA - NHIS (National Health Interview Survey) (2010) (ages 18+).
§ Australia - NDSHS (National Drug Strategy Househokd Survey) (2010) (ages 14+).574 PublicHealthReviews,Vol.33,No2
Smoking cessation
To determine smoking prevalence in a population, individuals are divided 
into  three  categories:  current  smokers,  ex-smokers  and  never  smokers. 
Ex-smoking prevalence is a good measure of cessation at a population 
level.1,32 An increase in cessation, along with increasing proportion of never 
smokers, has dropped adult (age 30 years or more) smoking prevalence in 
the UK between 1950-2005 from 70 percent to 25 percent in men and 40 
percent to 20 percent in women.28 There are now twice as many ex-smokers 
in the UK as smokers among those currently age 50 and older.33 Similar 
increases in cessation have been reported in most high-income countries.32 
For example, in Canada nearly 1.3 million adults over the age of 15 have 
quit smoking in the last decade, with increases also in the proportion of 
never smokers. In contrast, the prevalence of male ex-smokers in most low- 
and middle-income countries is low: below ten percent in China,34 Vietnam35 
and India36-37 (Figure 4). Even these low figures may be falsely elevated 
because they include people who quit because either they are too ill to 
continue or because of the early symptoms of tobacco-attributable illness, 
such as respiratory disease.
Fig. 4. Ex-smoking prevalence at ages 15 years or older among males in selected 
low- and middle-income countries, 2008-2010.
Source: From the Global Adult Tobacco Surveys.14-27ReducingSmokingDeathsWorldwide 575
Importance of prolonged smoking on disease risks
The vast majority of the world’s smokers today are below age 35.32 For 
these  individuals,  a  proper  understanding  of  the  hazards  of  continued 
smoking, and the corresponding benefits of cessation, must include an 
appreciation for the remarkably long delay between cause and full effect.38,39 
Indeed,  the  full  effects  of  smoking  can  take  50  years  to  measure  in 
individuals and up to 100 years to measure in populations. 
Widespread automation of cigarette production in the early 20th century 
turned cigarettes into a global commodity. Lung cancer was a rare disease 
prior to World War II, and the large increase in lung cancer rates lagged 
behind the onset of consumption by three or more decades. Among British 
doctors who were born in the first few decades of the 20th century (1900-
1930) and followed by those born in the second half of it (1951-2001), 
death rates were three times higher among doctors who smoked than those 
who did not.40 Furthermore, the smoker versus non-smoker relative risks of 
death became more extreme between in the period 1981-2001 than they 
were between 1951-1980.41 Prolonged smokers lost about ten years of life 
compared to non-smokers. Most, but not all, of the excess deaths from all 
causes among smokers was due to smoking, as there were no material 
differences among smokers, non-smokers and ex-smokers in education, 
drinking and obesity. Similarly, the main increase in male cigarette smoking 
in the US occurred from 1920-1940, and peaked at about 13 cigarettes per 
adult male only around 1960.28,42 Yet the rates of male lung cancer in middle 
age (defined here as about 30-69 years) and at older ages, almost all of 
which are due to smoking, peaked almost 30 years later (Figure 3).42-45 Note 
that long cancer rates at younger ages (such as 35-44 years) reflect more 
recent smoking in the population. 
The full effects of smoking have not yet been observed in low- and 
middle-income countries. China has over 300 million smokers16 and India 
has over 120 million smokers,18 most of whom are male (Figure 2). The 
mean consumption among Chinese men was one, four, and ten cigarettes 
per day in 1952, 1972 and 1992, respectively, which are comparable to 
increases reported 40 years earlier in the US.46,47 Moreover, China reports a 
marked increase in cigarette production since 2000, which might be from 
increased smoking among younger adults. India’s per capita adult male 
consumption is over six bidis or cigarettes per day, although there is some 
uncertainty in this, particularly for bidi use.37 This is comparable to the per 
capita adult consumption in France prior to 1990, and higher than that seen 
for adults today in Canada, which has declined from about 11 cigarettes per 
capita in 1960s to below five in 2010.29576 PublicHealthReviews,Vol.33,No2
Effects of cessation on lung cancer and total deaths
Widespread  smoking  cessation  in  high-income  countries  has  afforded 
researchers the opportunity to study the impact of quitting at various ages 
on the risk of death from tobacco-attributable diseases. UK doctors who 
quit smoking before the onset of major disease avoided most of the excess 
hazards of smoking. In comparison to those who continued smoking, the 
average gain in life expectancy for those who quit smoking at 60, 50, 40, 
and 30 years of age, was about three, six, nine, and nearly ten years, 
respectively.40
Fig. 5. Risk of death from lung cancer in smokers and ex-smokers. The age-specific 
probability of death from lung cancer for the US and UK, stratified by continued 
smoking or cessation at various ages are shown on the y-axes. UK data are from 
retrospective studies,33 courtesy of Richard Peto and Jill Boreham. Only selected 
smoking categories are displayed (never, stopped within 5 years of stated age, 
continued), and almost all smokers had used cigarettes. In each age range the 
relative risks match those in a case-control study of smoking, and an appropriately 
weighted average of the absolute risks matches the national lung cancer death rates. 
The US data are from the American Cancer Society prospective study of 1.2 million 
subjects during the first 10 years of follow-up, courtesy of Michael Thun.42 They 
omit the earlier years of follow-up (1981–83). Only selected smoking categories are 
displayed (never, stopped within 5 years of stated age, continued), and almost all 
smokers had used cigarettes. A minority of lung cancers is not due to smoking, but 
the US rates of lung cancer not due to smoking have changed little from the 1960s 
to  1990s.43,60,127 A  variety  of  genetic  factors  have  been  recently  suggested  that 
modestly predict lung cancer risk among smokers and non-smokers.128 However, it 
is improbable that marked shifts in genetic susceptibility have occurred, and even if 
they had, such shifts would not likely explain the dramatic changes in lung cancer 
seen over a few years or decades.39,42ReducingSmokingDeathsWorldwide 577
Cessation before middle age prevents more than 90 percent of the lung 
cancer mortality attributable to smoking, with quitters possessing a pattern 
of survival similar to that of persons who have never smoked. In the UK, 
among those who stopped smoking, the risk of lung cancer fell steeply with 
the amount of time since cessation.33 For men who quit at ages 50, 40, and 
30, the cumulative risks of lung cancer mortality by age 75 were six percent, 
three percent, and two percent, respectively. This contrasts greatly with the 
16 percent cumulative risk for continuing smokers. Similar reductions in 
risk of death from lung cancer have occurred in the US among men (Figure 
5) and women.42 The US study showed that few of those who quit smoking 
would restart. The absolute mortality reduction from cessation may be even 
greater for other diseases (particularly vascular diseases) than for lung 
cancer in the first decade or two after stopping smoking.40 Similar results 
on reductions in lung cancer risk among ex-smokers are seen in Poland.48 
In Germany and Italy, the excess lung cancer mortality avoided among men 
who quit smoking by age 40 was 91 percent, and 80 percent, respectively.49
CURRENT AND FUTURE DISEASE RISKS FROM SMOKING 
In this section, we briefly examine current cancer and total mortality, which 
reflects past exposure to smoking. Currently, about 70 percent of the 40 
million deaths among adults over age 30 years worldwide are due to cancer, 
vascular and respiratory diseases, and tuberculosis,50 each of which are 
made more common by smoking.8-11 Smoking currently causes about five 
to six million deaths annually worldwide from all causes (Table 2).2 About 
50 percent of all smoking deaths occur in low-income countries.
In 2001, cancer caused about 2.2 million male deaths and 1.6 million 
female deaths worldwide at ages 30-69 years.50 At these ages, smoking is 
estimated to cause about 31 percent and six percent of all cancer deaths in 
men and women, respectively. There has been a marked drop in male 
smoking deaths from cancer (and all causes) between 1975 and 2005 in the 
UK and the US.44,45 The 1975 male deaths reflected deaths among men who 
began to smoke about 1920-1940, near the peak of smoking rates in both 
countries,  when  cessation  was  uncommon.  Thus,  by  1975,  smoking 
accounted for more than 50 percent of all male cancer deaths and 34-44 
percent of deaths from all causes in middle age. By 2005, male cancer 
deaths from smoking fell to 23-26 percent of all UK and US male cancer 
deaths, and smoking deaths from all causes also fell. This decline was 
caused by a drop in the proportion of men who began smoking in 1950-
1970. Also a substantial proportion of this cohort of men ultimately quit 578 PublicHealthReviews,Vol.33,No2
smoking. The cancer and all-cause death rates from smoking among UK 
and US females peaked much later, around 1995, but have declined since. 
Table 2
Deathsinmiddleagemenandwomenfromallcauses(inthousands),
attributedtosmokinginselectedcountriesandworldwide
Men Women
Country or region (year) 
age group
Smoking deaths/ 
all causes deaths
% Smoking deaths/ 
total deaths
%
World (2001)
Age 30-693 2309/12263 19 489/8088 6
High-income
United Kingdom (1975) 
Age 35-6943  (2005)
62/142
18/78
44
23
15/85
11/51
18
21
United States (1975) 
Age 35-6943 (2005)
157/457
113/432
34
26
40/262
73/284
15
26
Low- or middle-income
India (2010) 
Age 30-6936
579/2882 20 93/2002 5
China (2000) 
Age 40+46
538/4172 13 135/4348 3
Where reliably measured, the proportion of cancer deaths currently due 
to  smoking  also  appears  to  be  substantial  in  low-  and  middle-income 
countries.36,46,51 In China, smoking caused about 28 percent of cancer deaths 
in men and six percent in women aged 40 or older in 2000.46,51 In India, 
about 32 percent and six percent of cancer deaths in men and women ages 
30-69 years, respectively, are caused by smoking.36,52 Smoking appears to 
synergise chronic viral infections that cause cervical cancers.53 
Smoking causes about three times as many non-cancer related deaths as 
it does cancer deaths. Cardiovascular disease is the leading cause of smoking-
attributable deaths worldwide, and accounts for about 1.5 million smoking 
deaths annually, of which 0.8 million deaths are from acute heart attack.2,50 
Smoking is a significant risk factor for both fatal and non-fatal heart attack 
and stroke.9,11,54,55 In high-income countries, about half of the male and a 
third of the female deaths from chronic lung disease are due to smoking.45 In 
China, chronic lung disease accounted for nearly half of all tobacco deaths 
among men age 30-69 years in 1990.46 Among those aged 30-69 years in 
India, over 30 percent of deaths among men and ten percent of the deaths 
among women from chronic lung disease are due to smoking in 2010.36ReducingSmokingDeathsWorldwide 579
In both countries, smoking appears to increase the high back  ground rates of 
chronic lung disease caused by indoor (not ambient) air pollution.56
Sir  Richard  Doll,  the  late,  renowned  epidemiologist,  observed  an 
association of smoking with tuberculosis in the 1950s in the UK,57 but 
widespread tuberculosis treatment caused the disease to become too rare to 
study in high-income countries. Hence the association with smoking was 
largely forgotten.8 More recently, increased risks of tuberculosis death and 
non-fatal tuberculosis among smokers have been observed in countries 
where tuberculosis remains common; most notably in India.36,58 In India, 
smoking  accounts  for  nearly  40  percent  of  tuberculosis  deaths  among 
middle-aged males, or about 120,000 deaths.36 Sub-clinical infection with 
the  tubercle  bacillus  is  widespread  and  smoking  appears  to  facilitate 
progression from silent to active clinical disease.36,58,59 Thus smoking might 
contribute to the spread of tuberculosis infection to others. 
Overall current smoker: non-smoker mortality risks
Provided due allowance is made for the long delay between smoking onset 
and disease, reasonably consistent quantitative estimates of risk emerge: 
about one in two of all long-term smokers worldwide are killed by their 
addiction.8,10,36,40,43-47,51,52,60,61 It is already apparent that a substantial portion 
of tobacco deaths worldwide occur in middle age (defined as 30-69 years): 
50 percent in the US and UK,43 50 percent in China46,51 and a surprisingly 
high 70 percent in India.36 Relative to non-smokers in India, male bidi 
smokers lose roughly six years, female bidi smokers lose about eight years, 
and male cigarette smokers lose about ten years of life.36 The ten year loss 
of life among Indian male cigarette smokers is already about as extreme as 
that observed among UK doctors40 who had started smoking early and 
stayed as life-long smokers. These high risks for the Indian smoker are seen 
despite the fact that average number of cigarettes smoked in India is less 
than in the UK and despite the fact that men in India start smoking at later 
ages than do men in the UK.
At present, about 80 percent of worldwide smoking deaths occur in 
men,2 but this is chiefly because men who died recently smoked more 
commonly and more intensively when they were young than did the female 
smokers. The smoker versus non-smoker mortality risks in US women after 
2000 are marginally greater than in men.61 Additionally, the consequences 
of smoking vary by socioeconomic group. For example, in several high-
income countries and Poland, smoking deaths were shown to account for at 
least half of the differences in middle age risk of death between rich, 
educated men and poorer, less educated men.62580 PublicHealthReviews,Vol.33,No2
Comparison of smoking and obesity mortality risks
Studies of tens of thousands of deaths have reliably assessed mortality from 
adult obesity and from persistent smoking in developed countries.63 In the 
Prospective  Studies  Collaboration  study64  of  70,000  deaths  in  900,000 
adults, an increase of two units in the body-mass index (BMI; the weight in 
kilograms divided by the square of the height in meters) among men who 
were overweight, reduced life span by one year (mostly from an increase in 
vascular disease death rates). This loss of one year of life was comparable 
to the reduction in life span with an increase of ten percent in the prevalence 
of smoking seen among UK doctors (Figure 6).40 Moderate obesity (over-
weight, defined as BMI range 30-35, mean 32) shortens life expectancy by 
approximately three years. Only among the small minority of adults with 
severe obesity (BMI range 40-50, mean 43) was the loss of life comparable 
to the ten years lost for being a life long smoker. Thus, stopping smoking 
(which is widely practicable) can lead to a gain of about ten years in life 
expectancy;  far  more  than  smokers  could  expect  from  weight  control 
(which is currently far less practicable). Note that the comparisons between 
the morbidity or health care costs of obesity and smoking are quite different 
to those examining mortality.65
Fig. 6. Mortality risks from smoking and obesity. Male survival, ages 35-100: 
severe obesity and cigarette smoking each shorten life expectancy by ~10 years, and 
moderate obesity shortens it by ~3 years; so, 2 kg/m2 extra BMI (if overweight) or 
a 10% prevalence of smoking shortens it by ~1 year. Left: Prospective Studies 
Collaboration  analyses  of  BMI  among  males;  effects  among  females  are  not 
greater.64  Right: Analyses  of  persistent  cigarette  smoking  among  male  British 
doctors.40ReducingSmokingDeathsWorldwide 581
Future risks from smoking
The  future  risks  of  smoking  among  men  in  low-  and  middle-income 
countries and women worldwide will depend on the duration of smoking 
(and cessation rates) in the population, variation in the diseases which are 
made common by smoking, and in the products and patterns of smoking. 
First, the full effects of smoking will be only apparent when the death rates 
from smoking in middle age among those who have started smoking as 
young adults rise 30-40 years later. Death rates from smoking in older age 
will rise only about 20 years after this.39 For example, of all US male deaths 
at ages 35-69, the proportion attributable to tobacco in 1950 was only 12 
percent, rising to 33 percent in 1990, when the increase in US male tobacco 
deaths had been completed (about three decades after peak male tobacco 
consumption).43 At present, there is some variation in the proportion of 
male smokers currently killed, being “only” 25 percent in China in 2000,46,51 
and about 40 percent in India in 2009.36 The higher risks among Indian 
males may reflect the fact that tuberculosis is more common in India than 
in China, as well as more prolonged smoking (smoking prevalence is higher 
among Chinese males but they have taken up smoking more recently than 
their Indian counterparts). The Chinese risks are likely to rise when the 
smokers who have been smoking throughout the decades from early adult 
life reach middle age. Second, average daily consumption of cigarettes or 
bidis is generally lower in low- and middle-income countries than in high-
income countries1,32,39 and the age of onset of smoking is usually later. 
Chinese men, however, have begun to start as young as US men.34 If similar 
shifts to smoking at younger ages occur in India and other populations, the 
hazards of smoking will be greater. Indeed, the future mortality risks from 
2010-2050 in China and India might be greater than that observed during 
the 1940-1980 period in the UK or the US. 
Third, in India’s case, a major shift from bidis to cigarettes appears to 
be underway,30 and if true, such a shift would substantially raise mortality 
risks. A  large  national  study  of  smoking  and  mortality  found  that  the 
relative risk of death from any medical cause depended on whether bidis or 
cigarettes were smoked and the amount smoked (Figure 7).36 The risk ratio 
for a given number of bidis or cigarettes smoked was greater for cigarettes 
than for bidis. For example, the relative risk of smoking one to seven bidis 
per day was 1.3 compared to the relative risk of 1.8 from smoking the same 
number of cigarettes per day. However, for both bidis and cigarettes, more 
daily smoking meant higher death risks, with particularly elevated risk 
ratios for smoking eight or more cigarettes a day (akin to the daily amount 
among smokers in western countries). 582 PublicHealthReviews,Vol.33,No2
Fig. 7. Relative Risk of Death by Amount and Type of Smoked Tobacco in Indian 
Men Aged 30-69. The relative risks are derived from a large nationally representative 
case control study.36 The risks are adjusted for education, alcohol use and age. 
Projected future death estimates
Plausible projections of future smoking deaths rely on smoking prevalence 
and uptake (cessation is minimal in low- and middle-income countries), 
growth in population and growth in the age-specific tobacco-attributable 
death rates. Sir Richard Peto6 estimates that global tobacco deaths will reach 
about 450 million between 2000 and 2050. His calculation is based on the 
following. About  100  million  people  a  year  reach  adult  life  worldwide. 
Current smoking uptake patterns suggest that there are about 30 million new 
smokers a year (i.e., about 50% of the young men, and 10% of the young 
women).28 Most will continue as cessation is uncommon currently outside 
high-income countries (Figure 4).32 Even assuming a large number, say ten of 
the 30 million do quit (or equivalently that the smoker versus non-smoker 
risks of eventual death are “only” 1 in 3 versus 1 in 2), then eventually ten 
million people a year will be killed by smoking. Worldwide annual tobacco 
mortality will rise to about ten million a year or 100 million per decade 
around  2030,  with  some  further  increases  in  later  decades.6  During  the 
25-year period from 2000-2025, there would be about 150 million tobacco 
deaths or about six million deaths per year on average; from 2025-2050, there 
would be about 300 million tobacco deaths, or about 12 million deaths per 
year. Further estimations are more uncertain, but based upon current initiation 
and cessation rates and projected population growth, from 2050–2100 there 
would be, conservatively, an additional 500 million tobacco deaths (i.e., 
average of 10 million deaths per year). Of the estimated one billion smoking-
attributable deaths in this century, most will be in low- and middle-income 
countries. In contrast, there were “only” 100 million tobacco deaths in the 
20th century, mostly in high-income and Eastern European countries who 
took up smoking en masse generally before or around World War II. ReducingSmokingDeathsWorldwide 583
Comparable projections for the next three to four decades have been 
made  by  others,1,5,66  and  the  projections  are  consistent  with  emerging 
epidemiological studies in China,46,47,51 and India36,52 Annual tobacco deaths 
in China are projected to rise to two million by 2025,46,47 when the young 
adult smokers of today reach middle age. Similarly, at current risks, India 
will have one million annual deaths during the 2010s36 and this number will 
rise with population growth. Similar growth in other populations in Asia, 
Eastern Europe, Latin America, the Middle East and, less certainly, sub-
Saharan Africa, suggest that Peto’s estimates of 50-60 million smoking 
deaths from 2000 to 2010 and about 400 million tobacco-attributable deaths 
from 2010 to 2050, are plausible. Indeed, the chief uncertainty is not if 
tobacco deaths will reach about ten million a year, but when, with the most 
likely scenario being around 2030.
ECONOMIC RATIONALE FOR GOVERNMENT INTERVENTION 
IN TOBACCO MARKETS
The public health argument for intervention in tobacco to reduce deaths 
could not be clearer. However, the tobacco industry and some economists 
have argued that increased taxation (and some other regulations on tobacco 
use) is inefficient and unwarranted on economic grounds.67 They claim that 
smokers smoke with full information about its health consequences and 
take into account the costs and benefits associated with its consumption. 
However, in practice, the market for tobacco products is characterised by at 
least three “market failures”.68-70 Two market failures relate to information: 
i) most consumers do not have full knowledge of risks associated with the 
consumption  of  tobacco,  and  ii)  consumers,  especially  young  smokers, 
underestimate the risk of addiction to tobacco. In India, few smokers know 
that 70 percent of smoking deaths occur during productive middle age or 
that the average years of life lost from smoking is as great as ten years,36 and 
less than 50 percent know that smoking is a cause of stroke18 and low 
proportion of adults in China know that smoking is a cause of heart attack.16 
In China fully 61 percent of smokers thought tobacco did them no or little 
harm.34 The lack of information on the full risks of smoking paired with the 
strongly  addictive  nature  of  manufactured  smoked  tobacco  results  in 
smokers facing high costs (withdrawal symptoms and physical distress) if 
they try to quit. In high-income countries with good information on smoking 
hazards, over 80 percent of adult smokers wish they had never started. Thus, 
there is no comparable consumer product that carries such severe health 
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high costs from the withdrawal of its use. Moreover, the tobacco industry 
specifically engineers cigarettes to be addictive, and designs reinforcing 
media messages and consumer signals to maintain this addiction.71 
The third market failure arises from health externalities from exposure 
to tobacco smoke and some financial externalities due to public spending to 
treat  diseases  caused  by  smoking.  Six  percent  to  15  percent  of  health 
spending is estimated to go toward tobacco-related diseases in developing 
countries.72 The direct cost of treating four major tobacco related diseases 
in India amounted to United States dollars (USD) 1.2 billion, or 4.7 percent 
of India’s national health care expenditure in 2004.73 Of course, the adage 
that the cheapest patient is a dead patient also applies to smoking-related 
deaths, and indeed some economists have argued that the death of smokers 
saves money for others in pension schemes.74 However, this argument relies 
on  the  false  assumption  that  smokers  are  fully  informed  about  their 
consumption choices. Moreover, the costs to households who lack formal 
insurance  schemes  or  pensions  and  in  whom  smoking-related  diseases 
leads to poverty or borrowing to treat the sick and loss of intergenerational 
wealth  transfers  is  likely  to  be  large.  A  recent  study  finds  that  after 
accounting for direct expenditure on tobacco by Indian households in 2004, 
tobacco consumption in India impoverishes roughly 15 million people.75 
Households with a smoker have worse child health outcomes, including 
lower immunisation rates in children.76,77
The biggest cost, of course, is the value of life foregone among smokers 
who wish to quit, but struggle against the strongly addictive properties of 
tobacco. Newer economic models that incorporate such real preferences78,79 
find a strong case for government intervention, and also find that taxation 
effectively  increases  the  welfare  of  smokers.  In  countries  with  good 
information, the vast majority of smokers themselves support much higher 
taxation on tobacco products.80
HOW CAN WORLDWIDE CESSATION RATES BE RAISED RAPIDLY
Cessation  by  today’s  smokers  is  the  only  practicable  way  to  avoid  a 
substantial proportion of tobacco deaths worldwide before 2050. Halving 
the worldwide per capita adult consumption of tobacco by 2020 (akin to the 
declines in adult smoking in the UK over the last three decades) would 
prevent about 160-180 million tobacco deaths over the next few decades.5,43 
In contrast, halving the percentage of children who become prolonged 
smokers (from about 30% to 15% over two decades) would prevent some 
20 million deaths over the next few decades, but its main effect would be to 
lower mortality rates in 2050 and beyond.1,5,6ReducingSmokingDeathsWorldwide 585
Aggressive  taxation  is  the  key  strategy  for  low-and  middle-income 
countries to reduce smoking at a rate faster than that achieved by high-
income countries. Powerful policy interventions to tax and regulate con-
sumption  and  to  inform  consumers  have  reduced  consumption  in  most 
high-income countries.28,33,68 The US and UK each took about 35 years and 
Canada about 25 years to halve per adult cigarette consumption (from about 
10 per adult per day to about 5).28 However, France took only 15 years to 
halve  consumption.81  France’s  uptake  of  smoking  was  chiefly  after  the 
Second World War and its prevalence rose until the mid-1980s. From 1990 
to 2005, cigarette consumption fell from about six cigarettes per adult per 
day to three cigarettes per adult per day (Figure 8). This sharp decline was 
mostly due to a sharp increase in tobacco taxation starting in 1990 under the 
then president Jacques Chirac. These price increases raised the inflation-
adjusted price threefold. Among men, the corresponding lung cancer rates at 
ages 35-44, which is a good measure of recent smoking in the population, 
fell sharply from 1997 onward. During this period, revenues in real terms 
rose from about six to 12 billion euros.81 Tax levels stagnated from 2004 
onward when Nicolas Sarkozy became finance minister as has the declines 
in per capita cigarette consumption. The decline in lung cancer was also due, 
more controversially, to replacement of high-tar with lower-tar cigarettes.82 
Fig. 8. France: smoking, tax and male lung cancer rates at young ages, 1980-2010. 
The per capita cigarette consumption, lung cancer death rates and relative price 
cigarettes are shown on the y-axes over time. Smoking per person per day and 
relative prices are provided by Catherine Hill.81 The lung-cancer death rates per 
100,000 are divided by four, so as to enable these to be on the same scale as smoking 
amount per day. Female lung cancer rates peaked later than the males, but have also 
halted their rise as of 2002.43 The stabilisation of smoking prevalence in the 1980-
1990 is due in part to the smaller earlier tax increases (Loi Veil) and to restrictions 
on advertising (Loi Evin). Further decreases in French smoking are reported after 
2008, when bans on public smoking appeared.586 PublicHealthReviews,Vol.33,No2
The  following  briefly  reviews  the  effectiveness  of  interventions  to 
reduce  tobacco  use  at  the  population  level.  More  detailed  reviews  are 
already published.1,5,68,69 
Tobacco taxation
Higher taxation is the single most important intervention to raising global 
smoking  cessation  rates.  Tobacco  taxes  and  consumption  are  strongly 
inversely  related  worldwide.83-85  Well  over  100  studies  worldwide 
demonstrate that increases in taxes on cigarettes and other tobacco products 
lead  to  significant  reductions  in  use.68,69,83-86  Studies  from  high-income 
countries estimate a ten percent increase in cigarette prices will reduce 
overall smoking by 2.5 percent to 5.0 percent in the medium term (within a 
few  years),83,85  and  perhaps  twice  this  in  the  longer-term  (5  years  or 
longer).83 The few studies from low- and middle-income countries suggest 
an effect twice as great: a ten percent increase in price will reduce smoking 
by eight percent in the medium term.85 Higher taxes reduce relapse and 
decrease consumption among continuing smokers. Half or more of the 
effect of price on cigarette demand results from reducing the number of 
current  smokers.87,88  Higher  taxes  increase  the  number  of  attempts  at 
quitting smoking and the success of those attempts; a ten percent increase 
in price results in 11 percent to 13 percent shorter smoking duration or a 
three percent higher probability of cessation.89 Higher cigarette prices are 
particularly effective in preventing young smokers from moving beyond 
experimentation  into  regular,  addicted  smoking90  and  among  the  less 
educated or lower-income individuals.91,92 This implies that tax increases 
will differentially reduce youth smoking in the future. 
Affordability is a concept that captures the interaction between con-
sumer’s  income  level  and  tobacco  prices.93  Typically,  affordability  is 
defined as gross income (GDP per capita relative to the wholesale price 
index for bidis or cigarettes). As price falls relative to income, affordability 
increases  and  vice  versa.  In  India,  bidis  are  nearly  three  times  more 
affordable in 2011 than they were in 1990, while cigarettes are about 175 
percent more affordable.30
High specific excise duties are far more likely to discourage switching 
between different types of tobacco products, are much easier to administer, 
and produce a much steadier stream of revenue.94 The exact impact of this 
excise duty structure would depend, of course, on the market conditions, 
industry efforts to counter the tax hike, and on large scale tax avoidance. 
Increases in excise duty decrease the differences between higher and lower 
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weakness is that such excise duties need to adjust periodically for inflation, 
which is much higher in developing than in developed countries. Thus a 
complementary strategy is to raise the excise duty every year, in line with 
overall inflation and preferably in excess of inflation, such that the number 
of ex-smokers increases every year. Australia and New Zealand have opted 
to raise tax rates above inflation automatically, rather than necessitating 
annual increases through the usual channels.94 France pursued such an 
objective starting in 1991, and increased cigarette prices by five percent or 
more in excess of inflation.95 In high inflation settings, it might make sense 
to focus on affordability, in which case tobacco taxes would be increased 
by enough to raise prices above income growth so as to reduce affordability.
An  increase  in  cigarette  taxes  of  ten  percent  globally  would  raise 
cigarette tax revenues by nearly seven percent, as the fall in demand is less 
than proportional to the price increase in most countries.1,68,69 However, 
taxes are underused in most developing countries.96,97 Taxes tend to be 
absolutely higher and account for a greater share of the retail price (71% as 
of 2006) in high-income countries. In low- and middle-income countries, 
taxes account for 54 percent of the final price of cigarettes.97 In South 
Africa, tax as a percentage of retail price fell to about 20 percent around 
1990,  but  has  subsequently  risen  to  nearly  40  percent.86  As  a  result, 
consumption fell from about four cigarettes per adult per day to two over a 
decade.86,98 Poland’s recent tax increases have doubled the real price of 
cigarettes99  and  dropped  consumption.  Mauritius  and  Mexico  recently 
raised taxes by about 30 percent, which has already produced a drop in 
consumption. 
A tax increase needed to raise the street prices of cigarettes by 70 
percent would involve a two to 2.8 fold increase across countries.5 The 
increase would raise the street price for a pack of 20 cigarettes from about 
USD 0.7 to 1.3 in low-income countries, from about USD 1.3 to USD 2.3 
in middle-income countries and from USD 3.7 to USD 6.3 in high-income 
countries. Such increases, while large, have been achieved in numerous 
countries, including Canada, France, Poland and South Africa and within 
the various states of the US. Indeed, price elasticity studies88 suggest that 
the 2.5 fold increase in the US federal cigarette tax as of 2009 (rising by 62 
cents to USD 1.01/pack) might get about one million Americans to quit 
smoking and deter another two million youth from starting, thus saving 
over one million lives.5588 PublicHealthReviews,Vol.33,No2
Health information and counter-advertising
It is often assumed that the health consequences of tobacco are well known 
worldwide because over 40,000 studies on smoking and health have been 
published over the last five decades.8 While general knowledge of health 
risks may be high in developed populations, awareness of the hazards of 
smoking  and  benefits  of  cessation  is  low  in  China,  India  and  other 
developing populations.100 
In high-income countries, smokers are more aware of the risks, but 
most smokers minimise the personal relevance of these risks.101 Smoking 
patterns in western countries have changed in response to control policies 
and increased information. Data on tobacco hazards helps build public 
support to implement control measures, such as higher prices and bans on 
advertising  and  promotion.68,69  Decreases  in  smoking  prevalence  were 
largest  in  high-income  countries  where  the  public  is  constantly  and 
consistently reminded of the dangers of smoking by extensive coverage of 
issues related to tobacco in the news media.1,100 For example, the 1962 
report  by  the  British  Royal  College  of  Physicians102  and  the  1964  US 
Surgeon  General’s  Report,103  in  combination  with  the  publicity  that 
followed each publication, reduced consumption by four to nine percent 
initially, and by 15-30 percent in the longer-term in both countries, and 
indeed  in  other  countries,  such  as  Switzerland.100,104  Thus,  counter-
advertising efforts, including focused mass publicity is likely to be effective 
in  low-  and  middle-income  countries.100  Prominent,  rotating  pictorial 
warning labels on tobacco products are effective at portraying risks to 
smokers,105 and would be particularly relevant where illiteracy is high (e.g., 
in India, half of the smoking deaths occur among the uneducated36). 
Restrictions on smoking in public places 
Restrictions on smoking in public places are intended chiefly to reduce 
non-smokers’ exposure to passive tobacco smoke and also to create non-
smoking  social  norms.  However,  comprehensive  restrictions  also  raise 
attempts  to  quit,  so  that  overall  consumption  falls  by  three  to  four 
percent.106-108 Admissions for acute heart attack have fallen in several high-
income settings who introduced restrictions on public smoking.108 Smoking 
bans in workplaces can reduce prevalence rates by up to 20 percent and 
reduce the quantity of cigarettes smoked among continuing smokers by five 
to 25 percent.108,109 These policies are most effective when strong social 
norms against smoking help to make smoking restrictions self-enforcing.110 ReducingSmokingDeathsWorldwide 589
Bans on advertising and promotion
Cigarettes are among the most heavily advertised and promoted products in 
the  world.  In  2005,  cigarette  companies  spent  USD  13.1  billion  on 
advertising and promotion in the US alone; the highest spending level 
reported to date.111 In high-income countries, comprehensive bans reduce 
consumption by about seven percent, taking into account differences in 
price and non-price control interventions112 and may be twice as effective in 
low-  and  middle-income  countries.113  However,  partial  bans  have  little 
effect, given that the tobacco industry shifts to other media or to promotion 
(such as rock concerts and web-based promotions). 
SMOKING CESSATION TREATMENTS
Pharmacological  treatments,  including  nicotine  replacement  therapies, 
bupropion, and varenicline, significantly improve the likelihood of quitting, 
with success rates two to three times those when pharmaceutical treatments 
are not employed.114 In addition, over-the-counter access to such medications 
increases access and decreases cost.115,116 A recent randomised trial in Poland 
found that cytisine, a cessation drug used commonly in the former socialist 
economies, was more effective than placebo for smoking cessation.117 As 
cytosine is much lower in price than standard drugs, it might be practicable 
in low and middle-income countries. 
Supply-side interventions
In contrast to the effective interventions designed to reduce demand, there 
is scant evidence indicating that restricting supply can be an effective way 
to reduce consumption. Limiting youth access to tobacco products, cross-
border trade restrictions, and crop substitution and diversification are mostly 
ineffective in reducing consumption, given that supply will always respond 
to demand.68,69 However, a key and effective intervention on the supply side 
is the control of smuggling. An estimated six to eight percent of cigarettes 
consumed globally are smuggled.118 The tobacco industry contributes to 
smuggling in order to reduce taxes and capture market share.119,120 Aside 
from harmonising prices between countries, effective measures to counter 
smuggling  include  prominent  tax  stamps  and  warning  labels  in  local 
languages, better methods for tracking cigarettes through the distribution 
chain,  aggressive  enforcement  of  anti-smuggling  laws,  and  stronger 
penalties.120,121 Even in the presence of smuggling, tax increases will reduce 
consumption and increase revenue.118 590 PublicHealthReviews,Vol.33,No2
THE FRAMEWORK CONVENTION ON TOBACCO CONTROL
The  main  vehicle  to  accelerate  tobacco  control  is  the  World  Health 
Organization’s Framework Convention on Tobacco Control (FCTC), which 
is the first ever global treaty on public health. This convention has been 
signed by over 160 countries.122 The FCTC has specific provisions for 
introduction of each of the evidence-based strategies noted above, in part as 
its formulation was driven by evidence from two major reviews of global 
tobacco control.68,69 More recently, the UN held a high level summit on 
non-communicable  diseases,  which  included  discussion  about  the 
importance of action on tobacco control.123
The main limitation of the FCTC is that it is a statement mostly of 
intent, and the specific actions needed to implement the provisions in each 
country require ongoing support for tobacco control.124 In particular, the 
implementation of higher tobacco taxes is the top priority, but demand 
considerable efforts to mobilize finance ministries, and not only health 
ministries. FCTC tax policy implementation needs to consider also the 
active influence of the tobacco industry, which seeks to make complex tax 
regimes which favour certain segments of the tobacco market,30 as well as 
outright  lobbying  to  confuse  governments  on  tobacco  taxes.125  More 
recently, the Bloomberg Philanthropies and the Bill and Melinda Gates 
Foundation have pledged, collectively, over 500 million USD to global 
tobacco control. If these funds are spent well, and focused on the above 
cost-effective interventions, then a substantial numbers of deaths might be 
avoided in the next few decades as a result of increased adult cessation, and 
even  more  deaths  avoided  in  the  second  half  of  the  21st  century  from 
avoidance of increases in youth smoking.126
CONCLUSION: AVOIDABLE TOBACCO DEATHS BEFORE 2050
Earlier estimates have examined the potential impact of a 70 percent price 
increase and a ten percent reduction from nonprice interventions such as 
bans on public smoking or information measures among the cohort of 1.1 
billion smokers alive in 2000.5 Price increases have the greatest impact on 
future tobacco mortality; a 70 percent higher price would prevent more 
than 110 million deaths, or one-quarter of all expected premature deaths 
from tobacco worldwide. Of avoided deaths, about 25 million would be 
from cancer and 50 million would be from vascular disease. Nonprice 
interventions would prevent 35 million deaths. The greatest impact of these 
tobacco control interventions would occur after 2015, but a substantial ReducingSmokingDeathsWorldwide 591
number of deaths could be avoided even prior to then. By 2030 to 2035, the 
expected annual toll of ten million deaths could be reduced to about seven 
million. 
In sum, on current smoking patterns, about one billion people will be 
killed in the 21st century by smoking. Without widespread cessation, about 
400 million people alive today will be killed by smoking between 2010 and 
2050. At least half will die at ages 30-69 years, losing decades of productive 
life, and those who smoke throughout adult life can expect to lose about 
one decade of life compared to non-smokers. Smoking-attributable cancer 
and total deaths have fallen sharply in high-income countries but will rise 
globally unless today’s smokers, most of whom live in low- and middle-
income countries, quit smoking before or during middle age. Tripling taxes 
on tobacco could rapidly raise cessation rates and deter smoking initiation. 
Higher taxes, increased regulations on smoking, and improved information 
for consumers could prevent at least 110 million smoking deaths in the next 
few decades.
Acronyms List:
FCTC = World Health Organization’s Framework Convention on Tobacco Control
Additional Material: Additional information on tobacco hazards in India, China, 
and developed countries (including updated results to 2005 on the UK, US and 
Poland) may be found at URLs: http://www.cghr.org/ and http://www.ctsu.ox.ac.
uk/deathsfromsmoking/ (accessed 31 August 2012). 
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